help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2008.080025 on August 7, 2008

Published online before print August 7, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2008.080025v1
173/3/631    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shweke, N.
Right arrow Articles by Boffa, J.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shweke, N.
Right arrow Articles by Boffa, J.-J.
(American Journal of Pathology. 2008;173:631-642.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.080025

Tissue Transglutaminase Contributes to Interstitial Renal Fibrosis by Favoring Accumulation of Fibrillar Collagen through TGF-β Activation and Cell Infiltration

Nasim Shweke*{dagger}, Nada Boulos*, Chantal Jouanneau*, Sophie Vandermeersch*, Gerry Melino{ddagger}, Jean-Claude Dussaule*{dagger}§, Christos Chatziantoniou*, Pierre Ronco*{dagger} and Jean-Jacques Boffa*{dagger}

From the INSERM UMR,* Paris, France; UPMC,{dagger} Université Paris 06, Paris, France; Biochemistry Laboratory, Department of Experimental Medicine,{ddagger} University Tor Vergata, Rome, Italy; Department of Physiology,§ Assistance Publique-Hôpitaux de Paris, Hopital Saint-Antoine, Paris, France; Department of Nephrology, Assitance Publique-Hôpitaux de Paris, Hôpital Tenon, Paris, France

Renal fibrosis is defined by the exaggerated accumulation of extracellular matrix proteins. Tissue transglutaminase (TG2) modifies the stability of extracellular matrix proteins and renders the extracellular matrix resistant to degradation. In addition, TG2 also activates transforming growth factor-β (TGF-β). We investigated the involvement of TG2 in the development of renal fibrosis using mice with a knockout of the TG2 gene (KO). These mice were studied at baseline and 12 days after unilateral ureteral obstruction, which induced a significant increase in interstitial TG2 expression in wild-type mice (P < 0.001). Interstitial fibrosis was evident in both groups, but total and fibrillar collagen was considerably lower in KO mice as compared with wild-type (P < 0.001). Similarly, mRNA and protein expression of collagen I were significantly lower in KO animals (P < 0.05). A statistically significant reduction in renal inflammation and fewer myofibroblasts were observed in KO mice (P < 0.01). Free active TGF-β was decreased in KO mice (P < 0.05), although total (active + latent) TFG-β concentration did not differ between groups. These results show that mice deficient in TG2 are protected against the development of fibrotic lesions in obstructive nephropathy. This protection results from reduced macrophage and myofibroblast infiltration, as well as from a decreased rate of collagen I synthesis because of decreased TGF-β activation. Our results suggest that inhibition of TG2 may provide a new and important therapeutic target against the progression of renal fibrosis.





This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
P. Mene and N. Pirozzi
Potassium channels: the 'master switch' of renal fibrosis?
Nephrol. Dial. Transplant., February 1, 2010; 25(2): 353 - 355.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Telci, R. J. Collighan, H. Basaga, and M. Griffin
Increased TG2 Expression Can Result in Induction of Transforming Growth Factor {beta}1, Causing Increased Synthesis and Deposition of Matrix Proteins, Which Can Be Regulated by Nitric Oxide
J. Biol. Chem., October 23, 2009; 284(43): 29547 - 29558.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. E. Iismaa, B. M. Mearns, L. Lorand, and R. M. Graham
Transglutaminases and Disease: Lessons From Genetically Engineered Mouse Models and Inherited Disorders
Physiol Rev, July 1, 2009; 89(3): 991 - 1023.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society for Investigative Pathology.